Axitinib as a third or further line of treatment in renal cancer: a single institution experience
Tsironis, G, Liontos, M, Kyriazoglou, A, Koutsoukos, K, Tsiara, A, Kaparelou, M, Zakopoulou, R, Cohen, A, Skafida, E, Fontara, S, Zagouri, F, Bamias, A, Dimopoulos, M A
Published in BMC urology (02.06.2020)
Published in BMC urology (02.06.2020)
Get full text
Journal Article